HCW Biologics Inc (HCWB)
1.12
0.00 (0.00%)
USD |
NASDAQ |
Jun 14, 16:00
HCW Biologics Market Cap: 42.36M for June 14, 2024
Market Cap Chart
Historical Market Cap Data
Date | Value |
---|---|
June 14, 2024 | 42.36M |
June 13, 2024 | 42.25M |
June 12, 2024 | 42.74M |
June 11, 2024 | 40.47M |
June 10, 2024 | 38.20M |
June 07, 2024 | 39.35M |
June 06, 2024 | 39.34M |
June 05, 2024 | 39.81M |
June 04, 2024 | 39.71M |
June 03, 2024 | 41.23M |
May 31, 2024 | 41.23M |
May 30, 2024 | 41.23M |
May 29, 2024 | 41.61M |
May 28, 2024 | 41.61M |
May 24, 2024 | 41.98M |
May 23, 2024 | 41.61M |
May 22, 2024 | 41.98M |
May 21, 2024 | 41.83M |
May 20, 2024 | 41.98M |
May 17, 2024 | 41.61M |
May 16, 2024 | 41.61M |
May 15, 2024 | 43.88M |
May 14, 2024 | 43.50M |
May 13, 2024 | 42.36M |
May 10, 2024 | 42.74M |
Date | Value |
---|---|
May 09, 2024 | 45.39M |
May 08, 2024 | 43.88M |
May 07, 2024 | 48.41M |
May 06, 2024 | 48.41M |
May 03, 2024 | 50.31M |
May 02, 2024 | 49.93M |
May 01, 2024 | 52.08M |
April 30, 2024 | 52.95M |
April 29, 2024 | 53.33M |
April 26, 2024 | 52.95M |
April 25, 2024 | 55.22M |
April 24, 2024 | 56.74M |
April 23, 2024 | 60.65M |
April 22, 2024 | 61.65M |
April 19, 2024 | 57.87M |
April 18, 2024 | 62.79M |
April 17, 2024 | 60.14M |
April 16, 2024 | 59.95M |
April 15, 2024 | 61.27M |
April 12, 2024 | 63.54M |
April 11, 2024 | 58.25M |
April 10, 2024 | 58.25M |
April 09, 2024 | 60.52M |
April 08, 2024 | 60.56M |
April 05, 2024 | 60.56M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
33.10M
Minimum
Nov 15 2023
224.60M
Maximum
Jul 20 2021
76.98M
Average
74.89M
Median
Market Cap Benchmarks
CEL-SCI Corp | 70.41M |
AIM ImmunoTech Inc | 23.03M |
IGC Pharma Inc | 26.60M |
NovaBay Pharmaceuticals Inc | 2.713M |
Protalix BioTherapeutics Inc | 83.58M |
Market Cap Related Metrics
PS Ratio | 10.34 |
PEG Ratio | -0.0283 |
Price to Book Value | 4.847 |
Price | 1.12 |
Earnings Yield | -67.86% |
PEGY Ratio | -0.0283 |